Advertisement
Latest News
- Ascendis’ weekly achondroplasia treatment recommended for EU approval
- Merck KGAA to acquire Silence Therapeutics for billions
- Former Novo Nordisk CEO nominated as Lundbeck chair
- China seeks to block foreign acquisitions of biotech platforms
- Ulf Landegren: From scientific discovery to successful companies
- Lilly’s new weight-loss pill recommended for EU approval
- Danish health minister: Europe must act on China
- AstraZeneca strikes 1.5 billion dollar AI drug discovery deal
- EMA backs Revolution’s pancreatic cancer drug after rapid review
- Lundbeck sells off factory in Italy
- Finnish biotech raises 28 million euros for next-generation allergy treatments
- GSK to cut 1,200 jobs in Belgium
- Modus shares halve after safety-related trial pause
- Zealand Pharma enters partnerships worth up to USD 1.2 bn
- Swedish Life Science industry needs more than another funding wish list
- Swedish electrode technology moves from lab to patients
- Oncopeptides raises SEK 100 million after brain cancer breakthrough
- This is how Denmark wants to renegotiate the MDR
- Teva wins FDA approval for schizophrenia injection
- Ambu expands their bronchoscopy offering
- Xbrane reaches milestone with biosimilar to blockbuster cancer drug
- He helped build Oslo Cancer Cluster – now AI is his next challenge
- Bristol Myers Squibb reports dual Phase III success
- MMI raises $125M for robotic surgery
- Camurus takes next step with Oczyesa – wins Canadian approval
- Per-Ola Carlsson honoured for diabetes research
- Decision on rival CAR-T therapies: Yes to Yescarta, no to Breyanzi
- Swedish medtech firm misses out on EU funding – files for bankruptcy
- Labour drug shortage in Sweden could be fixed by looking towards Denmark
- Abbott gets FDA nod for updated heart failure system
- Viatris to buy Pacira for $1.65 billion
- Pfizer wins new FDA approval for Tukysa in breast cancer
- Danish Care call out Danish government: “The industry is ready”
- Roche's Tecentriq gets FDA nod after strong colon cancer data
- Gothenburg researcher aims to launch CAR-T trial for childhood brain tumours
- European biopharma leaders are optimistic on funding issue, but it keeps them up at night
- Björn Arvidsson: “We skip the most important step after research”
- Nobel laureate’s CRISPR biotech shuts down as funding runs out
- How GLP-1 drugs are changing what we buy at the supermarket
- EU Discusses Suspected Pneumonic Plague Case in Russia
- WHO puts lifestyle changes before weight-loss drugs for children
- Mirror-image molecule discoveries win Nobel Prize in Chemistry
- Forbion raises €2.3bn in record life science fundraising
- Natural Cycles sharpens Nordic focus with new regional chief
- Stryker CEO steps down – company veteran takes over
- Medivir’s second act: three drugs to enter Phase 2
- AstraZeneca opens $1bn R&D centre in US
- Orexo seeks SEK 250 million to fund pipeline and DOJ settlement
- Nobel discovery helps explain cause and effect in the brain
- Novo's facility remediation delays haemophilia A drug
- Genmab scores Phase 3 win in blood cancer trial
- Omnio raises €2.9m for chronic wound therapy
- Russian lab worker’s death sparks suspected plague investigation
- Under-pressure CSL strikes billion-dollar deal – bets on new phase II candidate
- Discoveries in optogenetics awarded Nobel medicine prize
- New AI model could reduce unnecessary surgery for women
- Alligator slims down as new CEO takes over
- Novartis strikes $7.8bn deal with Chinese biotech
- Anocca doses first Swedish patient with its TCR-T therapy
- New heart valve can expand as children grow
- Danish diabetes firm secures MDR approval: “It's not something that you just do”
- Phase III goals met – yet Zealand shares fall
- Sanofi strikes another multibillion-dollar deal – four candidates in focus
- Novo slashes Wegovy price in Sweden – “It makes sense”
- €67.5m financing for Danish eyecare candidate
- Study finds key gut bacterium undetectable in one in three Swedish infants
- Swedish obesity challenger halts drug programme
- Danish biosolutions company expands U.S. factory
- Invisible hearing implant launched – entire device sits beneath the skin
- Swedish biotech AnaCardio raises €62.5m to advance heart failure drug
- Novo's Wegovy pill is being launched in Denmark – but not by themselves
- Anna Törner: Time for new body ideals?
- Kodiak shares more than double after positive eye drug results
- Phase III results approach for Cinclus – “We are hopeful”
- Novo Nordisk licenses weight-loss pill in deal worth up to 2.6 billion dollars
- Merck expands cancer pipeline with KRAS deal
- Egetis lands FDA approval: “Biggest milestone in the company’s history”
- AstraZeneca bets $2bn on Summit’s cancer drug
- Elekta shows promising results in pancreatic cancer
- Biontech to close three factories in Germany – 1,800 employees affected
- Swedish Alzheimer’s project wins 19 million dollar US research grant
- AbbVie wins FDA approval for new Parkinson’s treatment
- SciLifeLab set for major expansion in Stockholm
- ResoTher eyes pharma deal as heart attack candidate moves forward
- After Phase III setback – Diamyd sees effect in long-term follow-up
- Janne Backman takes over as chair of IRLAB
- Saline recalled after potentially dangerous mix-up
- Swedish biotech signs blockbuster deal with Novo – ”It’s Nanexa 2.0”
- Lundbeck relocates US headquarters and establishes innovation hub in Boston
- Multicancer blood test moves closer to FDA approval
- Elfcare to integrate health data with ChatGPT – leaves sharing to users
- Danish BioInnovation Institute sets sights on Europe
- Another round of job cuts at BMS headquarters
- Novartis makes a move in red‑hot radiopharma space
- Sweden takes half of Nordic spots among world’s top healthtech companies
- AstraZeneca receives EU approval for asthma treatment
Advertisement
Advertisement
Advertisement
News from our members
- Your UKRP Partner for Medical Device Market Access in the UK
- Kostnadseffektiv och driftsäker nivåmätning med Rosemount 1208
- Medical Device Software Process Design: Why IEC 62304 Matters
- Kostnadseffektiv automation för framtidens företag
- Your Partner for Clinical Study Submissions and Regulatory Interactions
Most read
Advertisement
Advertisement
BREAKING